MSMotahare Sharifyrad

Motahare Sharifyrad

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Motahare Sharifyrad has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Development and evaluation of a PLGA/TiO 2 nanocomposite for periodontal applications: Synthesis, characterization, and cytocompatibility with human gingival fibroblasts—An in vitro study

    by Atabak Kashefimehr, Samira Mohammad Mirzapour, Motahare Sharifyrad, Samira Beiraghisalek

    Background. Titanium dioxide (TiO2) nanoparticles exhibit promising antibacterial and structural properties but raise concerns of cytotoxicity in oral soft tissues. Incorporating TiO2 into biocompatible polymers such as poly(lactic-co-glycolic acid) (PLGA) may reduce these adverse effects and improve clinical applicability in periodontal therapy. Methods. TiO2 nanoparticles were synthesized via a modified sol–gel method and incorporated into PLGA matrices with and without polyvinylpyrrolidone (PVP) as a stabilizer. The formulations were characterized using Fourier-transform infrared (FTIR) spectroscopy, field emission scanning electron microscopy (FESEM), thermogravimetric analysis (TGA), dynamic light scattering (DLS), and x-ray diffraction (XRD). Cytocompatibility was evaluated using the MTT assay on HGF cells across concentrations of 1–100 μg/mL after 24 and 48 h. Results. TiO2 nanoparticles alone induced significant, dose- and time-dependent cytotoxicity, reducing cell viability to ~45% at 100 μg/mL after 48 h (P90% cell viability at all tested concentrations. The PLGA/TiO2 nanocomposite showed markedly reduced cytotoxicity, maintaining>80% viability even at 100 μg/mL. Incorporation of PVP improved nanoparticle dispersion, as confirmed by FESEM and DLS, and enhanced the thermal stability of the composite. Conclusion. Encapsulation of TiO2 within a PLGA matrix significantly mitigated cytotoxicity while preserving structural stability, with PVP further improving homogeneity and heat resistance. These findings highlight the potential of PLGA/TiO2 nanocomposites as safe and effective candidates for periodontal wound dressings, implant coatings, or regenerative scaffolds.


  • Open Access

    The synthesis and development of poly(ε-caprolactone) conjugated polyoxyethylene sorbitan oleate-based micelles for curcumin drug release: an in vitro study on breast cancer cells

    by Nasim Shadmani, Sepehr Gohari, Azin Kadkhodamanesh, Parivash Ghaderinia, Maryam Hassani, Motahare Sharifyrad

    Background: it is now known that curcumin (Cur) has a broad range of biological properties; however, photosensitivity, as well as low bioavailability and short half-life, have limited its clinical application. To overcome these problems the synthesis of poly(ε-caprolactone)–Tween 80 (PCL–T) copolymers was performed. Methods: the copolymers of PCL–T were created using the solvent evaporation/extraction technique. Then Cur was loaded in PCL–T micelles (PCL–T-M) by a self-assembly method. The characterization of copolymer and micelles was assessed by gel permeation chromatography (GPC), Fourier transform infrared spectroscopy (FT-IR), proton nuclear magnetic resonance spectroscopy (1HNMR), differential scanning calorimetry (DSC), transmission electron microscopy (TEM), and dynamic light scattering (DLS) methods. The MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay was used to indicate the cytotoxicity of the free Cur, PCL–T-M, and Cur-loaded PCL–T-M. Results: TEM analysis showed monodispersed and spherical shapes with a size of about 90 nm. Cur was released from PCL–T-M at pH 7.4 (45%) and 5.5 (90%) during 6 days. After 24 and 48 h, the IC50 of the free Cur, PCL–T-M, and Cur-loaded PCL–T-M on MCF-7 cells were 80.86 and 54.45 μg mL−1, 278.30 and 236.19 μg mL−1, 45.47 and 19.05 μg mL−1, respectively. Conclusion: this study showed that, in the same concentration, the effectiveness of the Cur-loaded PCL–T-M is more than the free Cur, and the nano-system has been able to overcome delivery obstacles of Cur drug. Thus, PCL–T-M can be a candidate as a drug carrier for the delivery of Cur and future therapeutic investigations on breast cancer.


  • Open Access

    Cytotoxicity of PLGA-zinc oxide nanocomposite on human gingival fibroblasts

    by Asieh Mozaffari, Samira Mohammad Mirzapour, Motahare Sharifi Rad, Mehdi Ranjbaran

    Background. Polylactic-co-glycolic acid and zinc oxide (PLGA-ZnO) nanocomposite has been investigated for its antibacterial properties, which could be beneficial for adding to wound dressings after periodontal surgery. However, its cytotoxicity against human gingival fibroblasts (HGFs) remains unclear and should be evaluated. Methods. ZnO nanoparticles were synthesized using the hydrothermal method. These metallic nanoparticles were incorporated into the PLGA matrix by the solvent/non-solvent process. The nanomaterial was evaluated by field emission scanning electron microscopy (FESEM), Fourier transform infrared (FTIR), thermogravimetric analysis (TGA), and x-ray diffraction (XRD) analyses. HGF cells were acquired from the National Cell Bank and categorized into four groups: ZnO, PLGA, ZnO-PLGA, and control. The cells were exposed to different ZnO (1, 20, 40, 60, 80, and 100 µg/mL) and PLGA (0.2, 4, 8, 12, 16, and 20 µg/mL) concentrations for 24 and 48 hours. The cytotoxicity was tested using the MTT assay. The data were analyzed using SPSS 25, and P<0.05 was considered statistically significant. Results. ZnO nanoparticles exhibited significant toxicity at≥40 µg/mL concentrations after 24 hours. Cell viability decreased significantly at all the tested concentrations after 48 hours of exposure. PLGA-ZnO cell viability in 24 hours was similar to the control group for all the concentrations up to 80 µg/mL. Conclusion. ZnO nanoparticles could be toxic against HGF in high concentrations and with prolonged exposure. Therefore, incorporating ZnO nanoparticles into a biocompatible polymer such as PLGA could be a beneficial strategy for reducing their toxicity.